Kupcová V, Turecký L, Brixová E
II. interná klinika LFUK v Bratislave, Slovakia.
Bratisl Lek Listy. 1993 Jul;94(7):354-60.
The authors describe a simple method of examination of galactose elimination capacity after intravenous administration of a twenty per cent solution in the total dose of 0.5 g galactose/kg body weight. After enzymatic determination of galactose concentration in six samples of venous blood (taken within 25, 30, 35, 40, 45 and 50 minutes after finishing the galactose infusion) the elimination curve of galactose and the intersection point with the time axis (t) is assessed and the galactose elimination capacity is calculated. In patients with liver steatosis and steatofibrosis, chronic hepatitis and liver cirrhosis the mean values of galactose elimination capacity were significantly lower in comparison with healthy volunteers. The method is sufficiently reliable, precise and quickly performable. It is suitable for evaluation and monitoring of the functional liver capacity, severity and progression rate of liver diseases. (Tab. 1. Fig. 2. Ref. 28).
作者描述了一种简单的方法,用于在静脉注射20%的溶液、总剂量为0.5g半乳糖/千克体重后检测半乳糖清除能力。在通过酶法测定六个静脉血样本(在半乳糖输注结束后25、30、35、40、45和50分钟内采集)中的半乳糖浓度后,评估半乳糖的清除曲线以及与时间轴(t)的交点,并计算半乳糖清除能力。与健康志愿者相比,患有肝脂肪变性、脂肪纤维化、慢性肝炎和肝硬化的患者的半乳糖清除能力平均值显著降低。该方法具有足够的可靠性、精确性且可快速执行。它适用于评估和监测肝功能、肝病的严重程度和进展速度。(表1。图2。参考文献28)